Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,337,500 | 1,563,800 | 2,290,200 | 2,036,400 | 7,320,700 |
| Marketable Securities | 101,000 | 89,200 | 77,700 | 100,700 | 88,200 |
| Receivables | 5,541,500 | 5,537,900 | 5,590,000 | 5,178,000 | 5,776,800 |
| Inventories | 3,190,700 | 3,101,300 | 3,181,100 | 3,055,200 | 3,098,100 |
| Other current assets | 0 | 0 | 0 | 0 | 2,229,100 |
| TOTAL | $13,709,600 | $12,661,800 | $13,454,500 | $12,597,500 | $20,549,600 |
| Non-Current Assets | |||||
| PPE Net | 7,872,900 | 7,801,500 | 7,847,500 | 7,780,000 | 7,996,100 |
| Investments And Advances | 1,962,400 | 1,825,300 | 1,852,700 | 2,111,400 | 2,005,400 |
| Intangibles | 6,618,000 | 6,689,300 | 6,586,600 | 6,641,500 | 1,068,000 |
| Other Non-Current Assets | 9,123,200 | 8,915,200 | 8,925,100 | 8,876,400 | 12,289,300 |
| TOTAL | $25,576,500 | $25,231,300 | $25,211,900 | $25,409,300 | $23,358,800 |
| Total Assets | $39,286,100 | $37,893,100 | $38,666,400 | $38,006,800 | $43,908,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,405,300 | 1,114,900 | 1,198,900 | 1,168,100 | 1,207,100 |
| Other current liabilities | 8,038,500 | 7,969,900 | 7,771,100 | 7,221,700 | 7,841,800 |
| TOTAL | $11,775,200 | $10,828,600 | $11,855,400 | $11,236,100 | $11,888,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,817,900 | 13,662,200 | 13,717,600 | 13,610,200 | 9,196,400 |
| Other Non-Current Liabilities | 8,806,400 | 7,526,300 | 7,855,200 | 8,196,000 | 10,602,100 |
| TOTAL | $24,811,800 | $23,602,200 | $23,953,700 | $24,205,700 | $21,111,200 |
| Total Liabilities | $36,587,000 | $34,430,800 | $35,809,100 | $35,441,800 | $32,999,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 956,382 | 960,131 | 965,433 | 970,831 | 1,035,419 |
| Common Shares | 598,800 | 600,400 | 603,700 | 607,100 | 661,000 |
| Retained earnings | 4,920,400 | 4,981,900 | 4,318,100 | 4,879,400 | 11,395,900 |
| Other shareholders' equity | -9,444,400 | -8,667,700 | -8,537,000 | -8,616,100 | -7,662,400 |
| TOTAL | $2,699,100 | $3,462,300 | $2,857,300 | $2,565,000 | $10,909,100 |
| Total Liabilities And Equity | $39,286,100 | $37,893,100 | $38,666,400 | $38,006,800 | $43,908,400 |